Vascular insulin-like growth factor-I resistance and diet-induced obesity

Endocrinology

Volumn 150, Issue 10, 2009, Pages 4575-4582

  Imrie, Helen ^a   Abbas, Afroze ^a   Viswambharan, Hema ^a   Rajwani, Adil ^a   Cubbon, Richard M ^a   Gage, Matthew ^a   Kahn, Matthew ^b   Ezzat, Vivienne A ^b   Duncan, Edward R ^a   Grant, Peter J ^a   Ajjan, Ramzi ^a   Wheatcroft, Stephen B ^a   Kearney, Mark T ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INSULIN; LIPID; NITRIC OXIDE; PHENYLEPHRINE; SERINE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BIOAVAILABILITY; BLOOD VESSEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IN VIVO STUDY; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN PHOSPHORYLATION; VASCULAR DISEASE; VASCULAR RING; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA; DIETARY FATS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHOSPHORYLATION; RECEPTOR, INSULIN; SERINE; VASODILATION;

EID: 70349321292     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1641     Document Type: Article

References (47)

1. Booth GL, Kapral MK, Fung K, Tu JV 2006 Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368:29-36 (Pubitemid 43947203)
2. Madala MC, Franklin BA, Chen AY, Berman AD, Roe MT, Peterson ED, Ohman EM, Smith Jr SC, Gibler WB, McCullough PA 2008 Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 52:979-985
3. Cubbon RM, Rajwani A, Abbas A, Gale CP, Grant PJ, Wheatcroft SB, Barth JH, Kearney MT, Hall AS 2007 Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehab 14:666-671 (Pubitemid 47556404)
4. Cubbon RM, Wheatcroft SB, Grant PJ, Gale CP, Barth JH, Sapsford RJ, Ajjan R, Kearney MT, Hall AS; Evaluation of Methods and Management of Acute Coronary Events Investigators 2007 Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J 28:540-545 (Pubitemid 47355504)
5. Cubbon RM, Gale CP, Rajwani A, Abbas A, Morrell C, Das R, Barth JH, Grant PJ, Kearney MT, Hall AS 2008 Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome. Diabetes Care 31:363-365 (Pubitemid 351213352)
6. Cubbon RM, Abbas A, Wheatcroft SB, Kilcullen N, Das R, Morrell C, Barth JH, Kearney MT, Hall AS; EMMACE-2investigators 2008 Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event. PloS One 3:e3483
7. Rader DJ, Daugherty A 2008 Translating molecular discoveries into new therapies for atherosclerosis. Nature 451:904-913 (Pubitemid 351301745)
8. Ross R 1999 Atherosclerosis is an inflammatory disease. N Engl J Med 340:115-126
9. Wheatcroft SB, Williams IL, Shah AM, Kearney MT 2003 Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20:255-268 (Pubitemid 36606117)
10. Williams IL, Chowienczyk PJ, Wheatcroft SB, Patel A, Sherwood R, Momin A, Shah AM, Kearney MT 2006 Fat distribution and endothelial function in healthy humans. Diabetes Obes Metab 8:296-301
11. Williams IL, Chowienczyk PJ, Wheatcroft SB, Patel AG, Sherwood RA, Momin A, Shah AM, Kearney MT 2005 Endothelial function and weight loss in obese humans. Obes Surg 15:1055-1060 (Pubitemid 41116894)
12. Wheatcroft SB, Shah AM, Li JM, Duncan E, Noronha BT, Crossey PA, Kearney MT 2004 Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Diabetes 53:2645-2652 (Pubitemid 39299274)
13. Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, Kearney MT 2007 Accelerated endothelial dysfunction in mild pre-diabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab 293:E1311-E1319
14. Duncan ER, Crossey PA, Walker S, Anilkumar N, Poston L, Douglas G, Ezzat VA, Wheatcroft SB, Shah AM, Kearney MT 2008 The effect of endothelium specific insulin resistance on endothelial function in vivo. Diabetes 57:3307-3314
15. Ezzat VA, Duncan ER, Wheatcroft SB, Kearney MT 2008 The role of IGF-I and its binding proteins in the development of type 2 diabetes mellitus and cardiovascular disease. Diabetes Obes Metab 10:198-211
16. Wheatcroft SB, Kearney MT 2009 IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab 20:153-162
17. Zeng G, Quon MJ 1996 Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98:894-898 (Pubitemid 26293305)
18. Noronha BT, Li JM, Wheatcroft SB, Shah AM, Kearney MT 2005 Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes 54:1082-1089
19. Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, Williams SC, Cawthorn WP, Medina-Gomez G, Vidal-Puig A, Sethi JK, Crossey PA 2007 Insulin-like growth factor binding protein-2 protects against the development of diet-induced obesity and insulin resistance. Diabetes 56:285-294
20. Viswambharan H, Ming XF, Zhu S, Hubsch A, Lerch P, Verge'res G, Rusconi S, Yang Z 2004 Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase. Circ Res 94:918-925 (Pubitemid 38490069)
21. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver S, Isner JM 1999 VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972 (Pubitemid 29335849)
22. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL 1995 Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95:2195-2204
23. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL 1999 Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104:447-457 (Pubitemid 29534329)
24. Steinberg HO, Chaker H, Leaming R, Johnson A, Bretchel G, Baron AD 1996 Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610 (Pubitemid 26187348)
25. Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, Haaparanta M, Knuuti J, Nuutila P 1998 Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 101:1156-1162 (Pubitemid 28125295)
26. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ 1990 Impaired vasodilation of forearm resistance vessels in hypercholesterolaemic humans. J Clin Invest 86:228-234 (Pubitemid 20226996)
27. Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, MacAllister RJ 2004 Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 64:172-178 (Pubitemid 39208934)
28. Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Lüscher TF 2000 Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101:1982-1989 (Pubitemid 30225281)
29. Monastyrskaya E, Folarin N, Malyshev I, Green C, Andreeva L 2002 Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 7:127-131
30. Schäfer A, Wiesmann F, Neubauer S, Eigenthaler M, Bauersachs J, Channon KM 2004 Rapid regulation of platelet activation in vivo by nitric oxide. Circulation 109:1819-1822 (Pubitemid 38509113)
31. Schächinger V, Britten MB, Zeiher AM 2000 Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906 (Pubitemid 30225269)
32. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G 2004 Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109:2518-2523 (Pubitemid 38720550)
33. Patel VA, Zhang QJ, Siddle K, Soos MA, Goddard M, Weissberg PL, Bennett MR 2001 Defect in insulin-like growth factor-1 survival mechanisms in atherosclerotic plaque derived vascular smooth muscle cells is mediated by reduced surface binding and signalling. Circ Res 88:895-902 (Pubitemid 32441467)
34. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T 2002 Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106:939-944 (Pubitemid 34925327)
35. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D 2004 The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89:114-120 (Pubitemid 38183869)
36. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM 2001 A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50:637-642 (Pubitemid 32195230)
37. Rasmussen MH, Juul A, Hilsted J 2007 Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism. Obesity (Silver Spring) 15:879-886 (Pubitemid 46740963)
38. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R 2004 Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150:161-171 (Pubitemid 38312809)
39. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim MB, Amit T 1992 The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 41:106-112
40. Utz AL, Yamamoto A, Sluss P, Breu J, Miller KK 2008 Androgens maymediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion. J Clin Endocrinol Metab 93:4033-4040
41. Delafontaine P, Song YH, Li Y 2004 Expression, regulation, and function of IGF-I, IGF-IR and IGF-I binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 24:435-444 (Pubitemid 38326135)
42. Copeland KC, Nair KS 1994 Recombinant human insulin-like growth factor-1 increases forearm blood flow. J Clin Endocrinol Metab 79:230-232
43. McCallum RW, Hamilton CA, Graham D, Jardine E, Connell JM, Dominiczak AF 2005 Vascular responses to IGF-I and insulin are impaired in aortae of hypertensive rats. J Hypertens 23:351-358 (Pubitemid 40279638)
44. Hasdai D, Nielsen MF, Rizza RA, Holmes Jr DR, Richardson DM, Cohen P, Lerman A 1999 Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor-I in experimental hypercholesterolaemia. Hypertension 34:89-95
45. Yang AL, Chao JI, Lee SD 2007 Altered insulin-mediated and insulin-like growth factor-1-mediated vasorelaxation in aortaes of obese Zucker rats. Int J Obes 31:72-77
46. Holzenberger M, Dupont J, Ducos B, Leneuve P, Géloën A, Even PC, Cervera P, Le Bouc Y 2003 IGF-I receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182-187 (Pubitemid 36090987)
47. Wheatcroft SB, Kearney MT, Shah AM, Grieve DJ, Williams IL, Miell JP, Crossey PA 2003 Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1. Diabetes 52:2075-2082